Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study

Background Biologic treatments have been studied mainly in patients with a long‐term history of psoriasis and previous treatment failures. Objectives The purpose of this primary analysis of the STEPIn study is to determine whether early intervention with secukinumab in patients with new‐onset modera...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2023-05, Vol.37 (5), p.1004-1016
Hauptverfasser:	Iversen, Lars, Conrad, Curdin, Eidsmo, Liv, Costanzo, Antonio, Narbutt, Joanna, Pinter, Andreas, Kingo, Külli, Rivera Diaz, Raquel, Kolbinger, Frank, Nanna, ManikPrabhu, Frueh, Jennifer Annika, Jagiello, Piotr
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological Products - therapeutic use Humans Immunoglobulin A Psoriasis - drug therapy Psoriasis - radiotherapy Severity of Illness Index Treatment Outcome Ultraviolet Therapy - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!